Home/ Supplements/ Omega 3/ OmegAvail Ultra DHA

OmegAvail Ultra DHA

product on market Softgel Capsule Designs for Health Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for OmegAvail Ultra DHA
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
Fat/Fatty Acid
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
10 {Calories}
Cholesterol
20 mg (2% DV)

Other Ingredients

natural Lemon flavor Lipase Mixed Tocopherols Bovine Gelatin Glycerine Water Annatto
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Recommended Use: As a dietary supplement, take one softgel per day with a meal, or as directed by your health care practitioner.

Warnings & Precautions

Contains fish. Manufactured from anchovies and sardines.

Warning: Consult with your health care practitioner before use if you are taking blood thinning medication or are planning to have surgery.

Formulation Notes

Contains fish. Manufactured from anchovies and sardines.

Does not contain gluten

OmegAvail(TM) Ultra DHA is molecularly distilled and filtered to ensure purity and to maximize the removal of metals, pesticides, PCBs, and other contaminants.

Lipase is added to enhance the digestibility and mixed tocopherols (antioxidants) are added to enhance stability of the product.

Additional Information

Notice: Color, size or shape may appear different between lots.

ODHA60

For Professional Use Only

TRUE TRIGLYCERIDE TruTG BOUND EPA & DHA(TM)

Guaranteed GMP COMPLIANT Products

Manufactured in an NSF GMP Registered Facility

STORE IN A COOL DRY PLACE.

Metadata

Product Details

UPC / SKU8 79452 00374 3
DSLD Entry Date2013-09-25
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID23410
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.